von Bismarck, O.; Dankowski, T.; Antony, G.; Ambrosius, B.; Ziegler, A.; Zipp, F.; Tackenberg, B.; Bergh, F. T.; Tumani, H.; Kuempfel, T. et al.; Stangel, M.; Heesen, C.; Wildemann, B.; Paul, F.; Bayas, A.; Warnke, C.; Weber, F.; Linker, R. A.; Ziemann, U.; Zettl, U. K.; Wiendl, H.; Hemmer, B.; Gold, R.; Salmen, A.: Neuropsychological impairment in newly diagnosed early multiple sclerosis: clinical and neuropsychological characterization of a German cohort of 1124 patients. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, October 25, 2017 - October 28, 2017. MULTIPLE SCLEROSIS JOURNAL 23 (Suppl. 3), P411, pp. 165 - 166 (2017)

Wincewicz, D.; Tolmunen, T.; Brem, A. K.; Kauhanen, J.; Lehto, S.: Preserved cognition and reduced age-related cognitive decline during treatment with angiotensin II receptor blockers: A 20-year follow-up study. 25th European congress of psychiatry (EPA), Florence, Italy, April 01, 2017 - April 04, 2017. EUROPEAN PSYCHIATRY 41 (Suppl.), EW0772, p. S372 - S372 (2017)

Wingo, A.; Lori, A.; Gillespie, C.; Kerley, K.; Jovanovic, T.; Binder, E.; Bradley, B.; Ressler, K.: Transcriptome-wide Analysis Identified Differential Expression of PID1, a Gene Implicated in Insulin Resistance, in High versus Low Psychological Resilience. 72nd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), San Diego, CA, May 18, 2017 - May 20, 2017. BIOLOGICAL PSYCHIATRY 81 (10, Suppl.), pp. S94 - S95 (2017)

Witt, S.; Lang, M.; Frank, J.; Gilles, M.; Dukal, H.; Send, T.; Hofmann, A.; Arloth, J.; Noethen, M.; Deuschle, M. et al.; Rietschel, M.: DNA METHYLATION MEDIATES THE EFFECT OF MATERNAL SMOKING DURING PREGNANCY ON BIRTHWEIGHT. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 3), pp. S507 - S508 (2017)

Wotjak, C. T.: Ethobehavioral assessment of innate fear and what endocannabinoids have got to do with it. Conference of the World Association for Stress Related and Anxiety Disorders (WASAD), Würzburg, GERMANY, September 14, 2017 - September 16, 2017. JOURNAL OF NEURAL TRANSMISSION 124 (10), p. 1291 - 1291 (2017)

Yehuda, R.; Bierer, L. M.; Bader, H. N.; Daskalakis, N. P.; Klengel, T.; Binder, E.: Second Generation Effects of Trauma: Evidence for Developmental Programming. 72nd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), San Diego, CA, May 18, 2017 - May 20, 2017. BIOLOGICAL PSYCHIATRY 81 (10, Suppl.), 90, p. S38 - S38 (2017)

Zannas, A. S.; Gassen, N. C.; Jia, M.; Baumert, J.; Hafner, K.; Ködel, M.; Haehle, A.; Iurato, S.; Carrillo-Roa, T.; Emeny, R. T. et al.; Lahti, J.; Raikkönen, K.; Eriksson, J.; Drake, A.; Waldenberger, M.; Wahl, S.; Kunze, S.; Lucae, S.; Bradley, B.; Gieger, C.; Hausch, F.; Smith, A. K.; Ressler, K. J.; Ludwig, K.-H.; Müller-Myhsok, B.; Rein, T.; Binder, E. B.: Aging- and stress-related epigenetic disinhibition of FKBP5 contributes to NF-κB-driven inflammation and cardiovascular risk. Conference of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Würzburg, Germany, September 14, 2017 - September 16, 2017. JOURNAL OF NEURAL TRANSMISSION 124 (10), p. 1292 - 1292 (2017)

Zannas, A.; Jia, M.; Baumert, J.; Hafner, K.; Ködel, M.; Hähle, A.; Iurato, S.; Carrillo Roa, T.; Emeny, R.; Lathi, J. et al.; Raikkonen, K.; Eriksson, J.; Drake, A.; Waldenberger, M.; Wahl, S.; Kunze, S.; Lucae, S.; Bradley, B.; Gieger, C.; Hausch, F.; Smith, A.; Ressler, K.; Müller-Myhsok, B.; Ladwig, K.-H.; Rein, T.; Gassen, N.; Binder, E.: Aging- and Stress-Related Epigenetic Disinhibition of FKBP5 Contributes to NF-KB-Driven Inflammation and Cardiovascular Risk. 56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), Palm Springs, CA, December 03, 2017 - December 07, 2017. NEUROPSYCHOPHARMACOLOGY 42 (Suppl. 1), T26, pp. S310 - S311 (2017)

Strotmann, J.; Klein, B.; Bautze, V.; Maier, A.-M.; Deussing, J.; Breer, H.: Activation of the mouse OR37 subsystem coincides with a reduction of novel environment-induced activity within the paraventricular nucleus of the hypothalamus. 25th Annual Meeting of the European Chemoreception Research Organization (ECRO), Istanbul, TURKEY, September 01, 2015 - September 05, 2015. CHEMICAL SENSES 41 (4), PS32, p. 400 - 400 (2016)

von Rueden, E.-L.; Bogdanovic, R. M.; Potschka, H.; Wotjak, C.: INDIRECT ACTIVATION OF THE ENDOCANNABINOID SYSTEM: 2-ARACHIDONOYLGLYCEROL MEDIATES CANNABINOID-DEPENDENT EFFECTS IN A MOUSE MODEL OF TEMPORAL LOBE EPILEPSY. 11th European Congress on Epileptology, Stockholm, SWEDEN, June 29, 2014 - July 03, 2014. EPILEPSIA 55 (Supplement s2), pp. 193 - 194 (2014)

Wu, Y.; Tedesco, L.; Schlitter, M.; Lucia, K.; Esposito, I.; Stalla, G. K.; Arzt, E.; Renner, U.: Expression of RSUME and its role in angogenic factor production in pancreatic neuroendocrine tumors. 57th Symposium of the German Society of Endocrinology, Dresden, March 19, 2014 - March 22, 2014. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 122 (3), P015, (2014)

Bertram, S.; Zhang, W.; Toyka, K. V.; Hatt, H.; Buchwald, B.: IMMUNOGLOBULIN G FROM PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) AFFECTS PRESYNAPTIC TRANSMITTER RELEASE AND CALCIUM INFLUX. 2009 Meeting of the Peripheral Nerve Society, Würzburg, July 04, 2009 - July 09, 2009. Journal of the Peripheral Nervous System 14 (Suppl. 2), p. 17 - 17 (2009)

Gerstner, N.; Krontira, A.; Knauer-Arloth, J.; Binder, E. B.: Brain region specific effects on the expression of glucocorticoid receptor-regulated genes. In EUROPEAN JOURNAL OF HUMAN GENETICS, 30 (SUPPL 1), p. 301 - 301. (2022)

Fietz, J.; Pöhlchen, D.; Brueckl, T. M.; Padberg, F.; Binder, E. B.; Czisch, M.; Saemann, P.; Spoormaker, V. I.: Patient stratification based on pupillometric response profiles and its brain correlates in affective and anxiety disorders. In JOURNAL OF NEURAL TRANSMISSION, 128 (11), p. 1773 - 1773. (2021)

Binder, E.: EMBEDDING OF EARLY ADVERSITY, MOLECULAR MECHANISMS AND GENETIC MODERATION - IMPLICATIONS FOR RISK TRAJECTORIES IN PSYCHIATRY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 51, p. E2 - E2. (2021)

Dieckmann, L.; Cruceanu, C.; Lahti-Pulkkinen, M.; Kvist, T.; Lahti, J.; Sammallahti, S.; Graebig-Rancourt, R. C.; Plagemann, A.; Eriksson, J. G.; Kajantie, E. et al.; Braun, T.; Entringer, S.; Raikkonen, K.; Binder, E. B.; Czamara, D.: APPLICATION OF REFERENCE-BASED CELL TYPE ESTIMATION IN PLACENTAL TISSUE AND COMPARISON WITH A REFERENCE-FREE APPROACH FOR DNA METHYLATION STUDIES. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 51, pp. E216 - E217. (2021)

Erhardt-Lehmann, A.: Stress-induced changes in DNA-methylation: focus on anxiety disorders. In JOURNAL OF NEURAL TRANSMISSION, 128 (11), p. 1798 - 1798. (2021)

Ku, H. P.; Forero, A.; Rivero, O.; Lesch, K. P.: Deficiency of Cadherin 13, a ADHD risk gene, impacts serotonergic circuit formation and cognitive function in mice. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 53, pp. S16 - S17. (2021)

Mikoteit, T.; Spieker, D.; Staeuble, C. K.; zu Schwabedissen, H. E. M.; Steiger, A.; Zeising, M. A.; Hatzinger, M.: Antidepressant response prediction by early response, prefrontal theta cordance in rapid-eye movement sleep and ABCB1 genotype. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 53, p. S517 - S517. (2021)

Vermoyal, J.-C.; Goirand-Lopez, L.; Vinck, A.; Fortoul, A.; Watrin, F.; Francis, F.; Cappello, S.; Marissal, T.; Manent, J.-B.: Comparative assessment of network-level defects in rodent models of subcortical band heterotopia and periventricular heterotopia. In EPILEPSIA, 62, p. 99 - 99. (2021)